These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Attacking migraine headache from beginning to end. Moskowitz MA; Cutrer FM Neurology; 1997 Nov; 49(5):1193-5. PubMed ID: 9371890 [No Abstract] [Full Text] [Related]
23. Targeting the 5-HT Huang PC; Yang FC; Chang CM; Yang CP Prog Brain Res; 2020; 255():99-121. PubMed ID: 33008517 [TBL] [Abstract][Full Text] [Related]
24. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat. Hoskin KL; Goadsby PJ Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827 [TBL] [Abstract][Full Text] [Related]
25. Mechanisms of action of the 5-HT1B/1D receptor agonists. Tepper SJ; Rapoport AM; Sheftell FD Arch Neurol; 2002 Jul; 59(7):1084-8. PubMed ID: 12117355 [TBL] [Abstract][Full Text] [Related]
33. Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials. Diener HC; Dowson AJ; Ferrari M; Nappi G; Tfelt-Hansen P Cephalalgia; 1999 Oct; 19(8):699-700. PubMed ID: 10570722 [No Abstract] [Full Text] [Related]
34. Emerging preclinical and clinical profile of 311C90: a poster review and discussion. Ferrari MD Eur Neurol; 1996; 36 Suppl 2():19-23. PubMed ID: 8791028 [No Abstract] [Full Text] [Related]
35. Inhibition of the trigemino-vascular system with 5-HT1D agonist drugs: selectively targeting additional sites of action. Martin GR Eur Neurol; 1996; 36 Suppl 2():13-8. PubMed ID: 8791027 [TBL] [Abstract][Full Text] [Related]
36. [Meta-analysis of triptan treatment in migraine]. Nakashima K; Takeshima T; Kowa H No To Shinkei; 2004 Sep; 56(9):747-52. PubMed ID: 15552863 [No Abstract] [Full Text] [Related]
37. Headache after frequent use of serotonin agonists zolmitriptan and naratriptan. Limmroth V; Kazarawa Z; Fritsche G; Diener HC Lancet; 1999 Jan; 353(9150):378. PubMed ID: 9950449 [No Abstract] [Full Text] [Related]
38. Serotonin 5HT1B/1D receptor agonists abolish NMDA receptor-evoked enhancement of nitric oxide synthase activity and cGMP concentration in brain cortex slices. Stepień A; Chalimoniuk M; Strosznajder J Cephalalgia; 1999 Dec; 19(10):859-65. PubMed ID: 10668104 [TBL] [Abstract][Full Text] [Related]
39. Activation of 5-hydroxytryptamine1B/1D/1F receptors as a mechanism of action of antimigraine drugs. Ramírez Rosas MB; Labruijere S; Villalón CM; Maassen Vandenbrink A Expert Opin Pharmacother; 2013 Aug; 14(12):1599-610. PubMed ID: 23815106 [TBL] [Abstract][Full Text] [Related]
40. Triptans to the rescue: effective therapy for migraine headaches in the workplace. Bartleson JD Mayo Clin Proc; 2000 Aug; 75(8):780-1. PubMed ID: 10943229 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]